Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
European Journal of Endocrinology|September 4, 1999
A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegalyR Cozzi, D Dallabonzana, R Attanasio, et al.The Journal of Clinical Endocrinology and Metabolism|January 1, 1985
Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptineP G Chiodini, A Liuzzi, D Dallabonzana, et al.Minerva Endocrinologica|January 1, 1990
[Medical treatment of acromegaly with dopaminergic agents]A Liuzzi, D Dallabonzana, G Oppizzi, et al.Neuroradiology|January 1, 1982
Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatmentG Scotti, G Scialfa, S Pieralli, et al.Journal of Endocrinological Investigation|April 1, 1985
Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomasG Verde, G Oppizzi, P G Chiodini, et al.European Journal of Endocrinology|November 27, 2001
Failure of radiotherapy in acromegalyR Cozzi, M Barausse, D Asnaghi, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1986
Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegalyR Cozzi, D Dallabonzana, G Oppizzi, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemiaD Dallabonzana, B Spelta, L Botalla, et al.The Journal of Clinical Endocrinology and Metabolism|December 1, 1986
Serum type III procollagen propeptide levels in acromegalic patientsG G Verde, I Santi, P Chiodini, et al.Journal of Endocrinological Investigation|April 1, 1985
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegalyD Dallabonzana, A Liuzzi, G Oppizzi, et al.Pageof 3